Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent
- PMID: 23842655
- DOI: 10.1001/jamadermatol.2013.4957
Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent
Abstract
Importance: Several chemotherapeutic agents have been reported to induce subacute cutaneous lupus erythematosus (SCLE). To our knowledge, this is the first report to date of SCLE induced by monotherapeutic gemcitabine hydrochloride and includes a comprehensive review of all published cases of chemotherapeutic drug-induced SCLE.
Observations: We describe a patient who developed a SCLE-like eruption after being administered gemcitabine and discuss 16 other published cases of chemotherapeutic drug-induced SCLE.
Conclusions and relevance: This case and a review of the literature call attention to gemcitabine and other chemotherapeutic agents that have been reported to cause drug-induced SCLE. We also discuss the clinical features of the disease.
Comment in
-
Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".JAMA Dermatol. 2013 Sep;149(9):1075-6. doi: 10.1001/jamadermatol.2013.4958. JAMA Dermatol. 2013. PMID: 23842706 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous